DAR ES SALAAM, Jan. 21 -- WE must admit it that Tanzania stands at a pivotal moment in its development journey. For decades, the country has relied heavily on imported medicines, vaccines, and medical supplies, exposing citizens to high prices, shortages, and vulnerability during global crises.

However, recent government investment in local pharmaceutical production signals a welcome shift toward self-reliance. Yet public funding alone will not deliver the scale, technology, and speed required. To succeed, Tanzanians must actively partner with experienced foreign investors and manufacturers.

This is because local drug production is not simply an economic ambition; it is a national security priority. For instance, the Covid-19 pandemic s...